Hims & Hers Health disclosed a transaction with the SEC, while Director David Wells acquired stock and TD Cowen covered the stock.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hims & Hers Health disclosed a transaction with the SEC, while Director David Wells acquired stock and TD Cowen covered the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hims & Hers Health
American telehealth company
Nothing else this week.
-
SEC
Slovak company
-
TD Cowen
American investment bank
Nothing else this week.
Related events
- A company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.
- Arcutis Biotherapeutics, Inc. disclosed an executive stock sale via a filing with the SEC on November 11, 2026.
- Danaher Corporation filed a transaction disclosure with the SEC.
- Goldman Sachs CEO David M. Solomon sold shares and filed the transaction with the SEC.
- Post Holdings disclosed a stock sale in a legal filing with the Securities and Exchange Commission.